Searchable abstracts of presentations at key conferences in endocrinology

ea0034p258 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

High serum amylase a contraindication to GLP1 analogue treatment?

Stepien Karolina , Kelly Anne-Marie , Horsman Graham , Younis Naveed

Case: A 41 year-old-Indian woman with type 2 diabetes treated with liraglutide was admitted to the Emergency Department with abdominal pain, nausea, vomiting and bloated abdomen. She was found to have raised amylase at 706 U/l. Abdominal ultrasound and CT scan did not reveal any abnormalities in the pancreas or billary tract and the patient was discharged.She had diabetes for 9 years duration treated with metformin, pioglitazone and liraglutide. Over 2 y...

ea0070aep606 | Pituitary and Neuroendocrinology | ECE2020

Clinical picture and MRI findings in patients with hypophysitis – a single-centre experience

Czajka-Oraniec Izabella , Stelmachowska-Banas Maria , Cylke Karolina , Zgliczynski Wojciech

Hypophysitis is a rare clinical condition manifesting as pituitary dysfunction: hypopituitarism or diabetes insipidus (DI) and pituitary enlargement causing mass effect (headaches, visual disturbances) due to the inflammation of the pituitary gland. We conducted a retrospective analysis of medical records of patients diagnosed with hypophysitis in the Department of Endocrinology of the Bielanski Hospital from 2014 to 2019. Twenty-five patients were identified, which represents...

ea0070aep922 | Thyroid | ECE2020

Impact ofhypothyroidism on early preneoplastic changes at the transcriptomic level in mammalian cells

Hanusek Karolina , Duda Monika , Piekiełko-Witkowska Agnieszka

Introduction: Studies suggest that disturbed thyroid hormones (TH) homeostasis may lead to increased cancer risk. However, the exact role of TH in cancerogenesis is unknown. We have previously identified 15 genes linked with TH signaling in 7 cancer types and 10.967 cancer patients. Here, we investigated the influence of hypothyroidism on the expression of these 15 genes in rat tissues/organs from which the previously identified, TH-related cancer types originate.<p class=...

ea0032p551 | Endocrine tumours and neoplasia | ECE2013

Adrenal incidentalomas – a retrospective analysis for the period 2001–2011

Nyvltova Monika , Vodak Miroslav , Drbalova Karolina , Zavoral Miroslav

Introduction: With the wider availability of imaging techniques there is an increasing number of newly diagnosed, accidentally found pathological formations in the adrenal glands known as adrenal incidentaloma (AI). Currently, the professional consensus is that hormonally active incidentalomas and those suspicious of malignancy should be indicated for surgery.Methods: In our retrospective study, we analyzed data of 141 patients with a total of 160 AIs, w...

ea0032p1059 | Thyroid (non-cancer) | ECE2013

Is TSH suppression an efficient thyroid nodular goitre therapy?

Drbalova Karolina , Vodak Miroslav , Nyvltova Monika , Tuckova Inna , Hill Martin

Levothyroxine suppression therapy, i.e. keeping the TSH value below 0.3 mIU/l with the aim to reduce the total thyroidal tissue or nodule volume, is an arguable and controversial issue not only due to the effect upon nodule volume but also because of the extent of necessary suppression, the effect of incomplete suppression, long-time therapeutic effects and risk of cardiovascular problems and osteoporosis.The incidence of nodular alterations rises with a...

ea0032p1076 | Thyroid (non-cancer) | ECE2013

Use of scintigraphy in the current diagnosis of thyroid diseases

Nyvltova Monika , Vodak Miroslav , Drbalova Karolina , Zavoral Miroslav

Introduction: Scintigraphy had long been the only modality for thyroid gland imaging. With the development of other imaging techniques (sonography, CT, MRI), the role of scintigraphy has gradually diminished. However, it cannot be completely ignored, as it is the only technique to image not only the morphological structure, but also the functional status of the thyroid gland. In the current clinical practice, thyroid scintigraphy is performed with 99mTc pertechnetat...

ea0056gp15 | Adrenal Case reports | ECE2018

Etomidate for the management of severe hypercortisolaemia in different clinical scenarios – a case series

Lebek-Szatanska Agnieszka , Nowak Karolina M , Zgliczynski Wojciech , Papierska Lucyna

Cushing’s syndrome is associated with life-threatening complications, as well as high rates of perioperative mortality and morbidity. Authors present clinical scenarios, in which one should consider the usage of intravenous etomidate as an accurate, safe and effective drug for hypercortisolaemia.Case 1: 23-year-old female with severe Cushing’s syndrome due to metastatic adrenocortical carcinoma was admitted to the Department of Endocrinology. S...

ea0073aep178 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

High prevalence of 1st trimester gestational diabetes mellitus in polish women is accompanied by insulin resistance similar to pcos cohort

Lewandowski Krysztof , Gluchowska Monika , Garnysz Karolina , Horzelski Wojciech , Lewinski Andrzej

Back groundBoth pregnancy and polycystic ovary syndrome (PCOS) constitute insulin-resistant states, while gestational diabetes (GDM) is associated with adverse pregnancy outcomes. Though screening for GDM is typically performed later in pregnancy, some women demonstrate significant insulin resistance (IR) and develop GDM even in 1st trimester. We have endeavoured to compare surrogate IR indices in 1st trimester pregnant women and in...

ea0073aep325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of glucocorticoid receptor gene polymorphism A3669G (9β) with lower glucose concentration 2 hours after OGTT in patients during chronic glucocorticoid treatment

Nowak Karolina , Sobalska-Kwapis Marta , Zgliczynski Wojciech , Papierska Lucyna

Background2–3% of the general population is chronically treated with glucocorticoids (GCs). Modification of the structure and/or function of the glucocorticoid receptor (GR) due to its polymorphisms may result in increased (GC – S – bclI, N363S) or decreased (GC – I – A3669G, ER22/23EK) sensitivity to GCs. To date, whether such modulation of cell’s response to GCs can be associated with presence or absence of the side effect...

ea0094p78 | Metabolism, Obesity and Diabetes | SFEBES2023

Endocrine consequences of inherited metabolic disorders: Experience from a joint clinic

Bassett John , Puente Nuria , Heald Adrian , Stepien Karolina

Introduction: Substrate accumulation, energy deficiency or complex molecule defects characterize inherited metabolic disorders (IMDs), accounting for their multi-system manifestations. One important aspect of this is endocrinopathy, which is relatively common but underestimated in IMDs, presenting in childhood following diagnosis or sometimes a presenting symptom in adults where there is multi-system or multi-gland involvement. Endocrinopathies may be secondar...